df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.1 KiB
3.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by certain federal agencies | Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by the United States food and drug administration, the centers for Medicare and Medicaid services, or the United States department of health and human services. | us/states/ny | New York Legislature | 2023-2024 | A 997 | New York A 997 (2023-2024) |
|
enacted |
|
1 | 14 | 2 | 2023-01-12 | 2023-03-03 | openstates | ocd-bill/a4c46175-b5ca-4863-8fbe-cfa1b33c33d7 | http://www.nysenate.gov/legislation/bills/2023/A997 | f4ca0263318061a7cd8522081213070724544a41b407dfdb99dfa73bcde2e3fd | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York A 997 (2023-2024) — Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by certain federal agencies
Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by the United States food and drug administration, the centers for Medicare and Medicaid services, or the United States department of health and human services.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- A997 (committee substitute) — source
Votes
- Assembly Vote — 144–0 (pass) · lower
- Floor Vote — 61–0 (pass) · upper
Sponsors
- Phara Souffrant Forrest — primary (person)
- Rodneyse Bichotte Hermelyn — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2023-01-12 REFERRED TO HEALTH
referral-committee - 2023-01-17 REPORTED REFERRED TO RULES
referral-committee - 2023-01-17 REPORTED
- 2023-01-17 RULES REPORT CAL.16
- 2023-01-17 ORDERED TO THIRD READING RULES CAL.16
- 2023-01-18 PASSED ASSEMBLY
passage - 2023-01-18 DELIVERED TO SENATE
- 2023-01-18 REFERRED TO RULES
referral-committee - 2023-02-07 SUBSTITUTED FOR S1342
- 2023-02-07 3RD READING CAL.110
- 2023-02-07 PASSED SENATE
passage - 2023-02-07 RETURNED TO ASSEMBLY
- 2023-03-03 DELIVERED TO GOVERNOR
executive-receipt - 2023-03-03 SIGNED CHAP.41
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/a4c46175-b5ca-4863-8fbe-cfa1b33c33d7. Confidence: reported (aggregated from official New York legislature records).